Incidence and risk factor analysis for sarcopenia in patients with cancer

Oncology Letters

Volumn 11, Issue 2, 2016, Pages 1230-1234

  Zhang, Guoxing ^a   Li, Xiujiang ^a   Sui, Changping ^a   Zhao, Hui ^a   Zhao, Jihong ^a   Hou, Yue ^b   Du, Yujun ^b  

^a Jilin Province Tumor Hospital   (China)

^b THE FIRST HOSPITAL OF JILIN UNIVERSITY   (China)

Author keywords

Cancer; Cluster of differentiation 4; Cluster of differentiation 8; Lymphocytes; Sarcopenia

Indexed keywords

ALBUMIN;

ADIPOSE TISSUE; ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NEOPLASM; NUCLEAR MAGNETIC RESONANCE IMAGING; RISK FACTOR; SARCOPENIA; SCORING SYSTEM; VERY ELDERLY;

EID: 84954357761     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2015.4019     Document Type: Article

References (26)

1. Ryall JG, Schertzer JD and Lynch GS: Cellular and molecular mechanisms underlying age-related skeletal muscle wasting and weakness. Biogerontology 9: 213-228, 2008.
2. Visser M: Towards a definition of sarcopenia - results from epidemiologic studies. J Nutr Health Aging 13: 713-716, 2009.
3. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, Martin FC, Michel JP, Rolland Y, Schneider SM, et al; European Working Group on Sarcopenia in Older People: Sarcopenia: European consensus on definition and diagnosis: Report of the European working group on sarcopenia in older people. Age Ageing 39: 412-423, 2010.
4. Mitchell WK, Williams J, Atherton P, Larvin M, Lund J and Narici M: Sarcopenia, dynapenia, and the impact of advancing age on human skeletal muscle size and strength; a quantitative review. Front Physiol 3: 260, 2012.
5. Tisdale MJ: Pathogenesis of cancer cachexia. J Support Oncol 1: 159-168, 2003.
6. Janssen I, Shepard DS, Katzmarzyk PT and Roubenoff R: The healthcare costs of sarcopenia in the United States. J Am Geriatr Soc 52: 80-85, 2004.
7. Wingo PA, Ries LA, Rosenberg HM, Miller DS and Edwards BK: Cancer incidence and mortality, 1973-1995: A report card for the U.S. Cancer 82: 1197-1207, 1998.
8. Brenner H: Long-term survival rates of cancer patients achieved by the end of the 20th century: A period analysis. Lancet 360: 1131-1135, 2002.
9. Gutierrez EG, Banks WA and Kastin AJ: Murine tumor necrosis factor alpha is transported from blood to brain in the mouse. J Neuroimmunol 47: 169-176, 1993.
10. DeWys WD: Anorexia as a general effect of cancer. Cancer 43 (Suppl): 2013-2019, 1979.
11. Reeds PJ, Fjeld CR and Jahoor F: Do the differences between the amino acid compositions of acute-phase and muscle proteins have a bearing on nitrogen loss in traumatic states? J Nutr 124: 906-910, 1994.
12. Deans DA, Wigmore SJ, Gilmour H, Paterson-Brown S, Ross JA and Fearon KC: Elevated tumour interleukin-1beta is associated with systemic inflammation: A marker of reduced survival in gastro-oesophageal cancer. Br J Cancer 95: 1568-1575, 2006.
13. Fearon KC: The Sir David Cuthbertson Medal Lecture 1991. The mechanisms and treatment of weight loss in cancer. Proc Nutr Soc 51: 251-265, 1992.
14. Bryant D, Becker L, Richardson J, Shelton J, Franco F, Peshock R, Thompson M and Giroir B: Cardiac failure in transgenic mice with myocardial expression of tumor necrosis factor-alpha. Circulation 97: 1375-1381, 1998.
15. Ramos EJ, Suzuki S, Marks D, Inui A, Asakawa A and Meguid MM: Cancer anorexia-cachexia syndrome: Cytokines and neuropeptides. Curr Opin Clin Nutr Metab Care 7: 427-434, 2004.
16. Donohoe CL, Ryan AM and Reynolds JV: Cancer cachexia: Mechanisms and clinical implications. Gastroenterol Res Pract 2011: 601434, 2011.
17. Mourtzakis M, Prado CM, Lieffers JR, Reiman T, McCargar LJ and Baracos VE: A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care. Appl Physiol Nutr Metab 33: 997-1006, 2008.
18. Shen W, Punyanitya M, Wang Z, Gallagher D, St-Onge MP, Albu J, Heymsfield SB and Heshka S: Total body skeletal muscle and adipose tissue volumes: Estimation from a single abdominal cross-sectional image. J Appl Physiol (1985) 97: 2333-2338, 2004.
19. Bosaeus I, Daneryd P, Svanberg E and Lundholm K: Dietary intake and resting energy expenditure in relation to weight loss in unselected cancer patients. Int J Cancer 93: 380-383, 2001.
20. Antoun S, Baracos VE, Birdsell L, Escudier B and Sawyer MB: Low body mass index and sarcopenia associated with dose-limiting toxicity of sorafenib in patients with renal cell carcinoma. Ann Oncol 21: 1594-1598, 2010.
21. Prado CM, Lieffers JR, McCargar LJ, Reiman T, Sawyer MB, Martin L and Baracos VE: Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: A population-based study. Lancet Oncol 9: 629-635, 2008.
22. Poortmans JR, Carpentier A, Pereira-Lancha LO and Lancha Jr A: Protein turnover, amino acid requirements and recommendations for athletes and active populations. Braz J Med Biol Res 45: 875-890, 2012.
23. Pahor M and Kritchevsky S: Research hypotheses on muscle wasting, aging, loss of function and disability. J Nutr Health Aging 2: 97-100, 1998.
24. Williams JP, Phillips BE, Smith K, Atherton PJ, Rankin D, Selby AL, Liptrot S, Lund J, Larvin M and Rennie MJ: Effect of tumor burden and subsequent surgical resection on skeletal muscle mass and protein turnover in colorectal cancer patients. Am J Clin Nutr 96: 1064-1070, 2012.
25. Akbulut G: New perspective for nutritional support of cancer patients: Enteral/parenteral nutrition. Exp Ther Med 2: 675-684, 2011.
26. Santarpia L, Contaldo F and Pasanisi F. Nutritional screening and early treatment of malnutrition in cancer patients. J Cachexia Sarcopenia Muscle 2: 27-35, 2011.